Longitudinal assessment of BMI in relation to ADT use among early stage prostate cancer survivors

Introduction The use of androgen deprivation therapy (ADT) for prostate cancer is on the rise, but its adverse side effects may include increased fat mass and decreased lean muscle mass. The net effect of ADT on BMI is unknown. Methods Primary, incident cases of early stage prostate cancer ( n  = 47...

Ausführliche Beschreibung